Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Intensity Therapeutics Inc (NASDAQ: INTS) was $0.32 for the day, down -2.03% from the previous closing price of $0.32. In other words, the price has decreased by -$2.03 from its previous closing price. On the day, 3.16 million shares were traded. INTS stock price reached its highest trading level at $0.335 during the session, while it also had its lowest trading level at $0.3169.
Ratios:
Our analysis of INTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INTS now has a Market Capitalization of 8302120 and an Enterprise Value of 4850248.
Stock Price History:
The Beta on a monthly basis for INTS is 3.80, which has changed by -0.9331276 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, INTS has reached a high of $4.94, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -16.39%, while the 200-Day Moving Average is calculated to be -83.00%.
Shares Statistics:
INTS traded an average of 2.14M shares per day over the past three months and 5141350 shares per day over the past ten days. A total of 15.26M shares are outstanding, with a floating share count of 14.05M. Insiders hold about 46.12% of the company’s shares, while institutions hold 9.99% stake in the company. Shares short for INTS as of 1749772800 were 659567 with a Short Ratio of 0.19, compared to 1747267200 on 157645. Therefore, it implies a Short% of Shares Outstanding of 659567 and a Short% of Float of 3.18.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
